Showing results (41-50 of 115) with videos related to
Sort By:
Pageof 12
Genes, Chromosomes & Cancer|August 31, 2004
Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemiaXin Ying Su, Maryvonne Busson, Véronique Della Valle, et al.Cancer Cell|July 11, 2018
Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic LeukemiaChelsea L Dieck, Gannie Tzoneva, Farhad Forouhar, et al.Blood|March 27, 2004
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemiasElisabeth Paietta, Adolfo A Ferrando, Donna Neuberg, et al.Blood|January 24, 2020
Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemiaMalwine J Barz, Jana Hof, Stefanie Groeneveld-Krentz, et al.The Journal of Investigative Dermatology|January 14, 2024
Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell LymphomaBobby B Shih, Cindy Ma, Jose R Cortes, et al.Lancet (London, England)|February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemiaAdolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.Science (New York, N.Y.)|February 8, 2003
Myc-induced T cell leukemia in transgenic zebrafishDavid M Langenau, David Traver, Adolfo A Ferrando, et al.The Journal of Experimental Medicine|November 22, 2017
Leukemia-specific delivery of mutant NOTCH1 targeted therapyGiovanni Roti, Jun Qi, Samuel Kitara, et al.Proceedings of the National Academy of Sciences of the United States of America|March 19, 2017
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemiaGiulia Fabbri, Antony B Holmes, Mara Viganotti, et al.Blood|November 15, 2003
IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALLJoao T Barata, Vassiliki A Boussiotis, Jose A Yunes, et al.Pageof 12